TeleRay is an industry-first telehealth and image management platform. TeleRay cloud-based medical image management platform allows users to securely share images with professionals (specialists, referring, clinicians) and patients. The platform has many features, including the ability to import or convert DICOM or non DICOM images, query and HL7 connectivity. Integrate with any EMR, view images on an FDA approved viewer anywhere on any device.
Complete DICOM image migration is available- set up, training, and implementation is included. Live streaming and remote control of modalities are options and great for many use cases to place professionals virtually in a room any where.
TeleRay is the most secure platform with peer 2 peer health and data communication. You can use the app to access workflow tools like waiting rooms, multi-calls, call transfer and sharing of images. It's simple and affordable.
More than 3000 locations use our service, including 38 of the top medical centers in more than 20 nations. Get started today for free.
Learn more
Improve radiology reporting efficiency and report quality with Imorgon's reporting automation.
As the top DICOM SR software for radiology, our solution significantly reduces unnecessary dictation by precisely transferring ultrasound and DEXA modality measurements into Powerscribe, Fluency, or RadAI. This eliminates manual errors and significantly accelerates the generation of reports.
Imorgon's unique advantages include:
- guaranteed transfer of all measurements - usually DICOM SR
- electronic worksheets for direct report population (eliminating dictation from notes)
- worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc)
- integration with Epic and other EHRs.
- vendor-neutral
Our dedicated support team ensures uninterrupted workflow.
Invest in Imorgon for a quick and substantial return on investment, transforming your reporting overhead into a streamlined, high-quality operation.
Learn more
See-Mode
See-Mode Technologies is a MedTech firm focused on utilizing AI to enhance ultrasound reporting, thereby boosting both diagnostic accuracy and operational efficiency. Their innovative platform swiftly analyzes ultrasound images of the thyroid and breast, resulting in rapid and precise radiology reports. By identifying, measuring, and characterizing nodules, See-Mode produces a comprehensive TI-RADS sonographer worksheet along with initial impressions for radiologists. In the realm of breast imaging, the software not only detects lesions but also automates the BI-RADS reporting process, offering detailed insights into lesion characteristics and levels of suspicion. This advanced technology minimizes inter-operator variability and reduces the likelihood of reporting errors, ultimately strengthening diagnostic confidence and ensuring consistency. By streamlining the reporting process, See-Mode facilitates more informed clinical decisions, which can lead to better patient outcomes.
Learn more
Oncoustics
Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.
Learn more
